Miguel E Aguado-Barrera
Overview
Explore the profile of Miguel E Aguado-Barrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Pleguezuelos C, Aguado-Barrera M, Carballo-Castro A, Peleteiro P, Calvo-Crespo P, Taboada-Valladares B, et al.
Clin Epigenetics
. 2025 Mar;
17(1):43.
PMID: 40050897
Background: Prostate cancer is the second most common cancer globally, with radiation therapy (RT) being a key treatment for clinically localized and locally advanced cases. Given high survival rates, addressing...
2.
Farazi M, Yang X, Gehl C, Barnett G, Burnet N, Chang-Claude J, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40029246
Background: Late bladder toxicity is a concern for patients receiving prostate cancer radiotherapy and negatively impacts survivors. Few risk factors are known beyond the radiation dose and volume of bladder...
3.
Aguado-Barrera M, Lopez-Pleguezuelos C, Gomez-Caamano A, Calvo-Crespo P, Taboada-Valladares B, Azria D, et al.
Lung Cancer
. 2024 Dec;
199:108072.
PMID: 39740425
Background And Purpose: We investigate discrepancies in the assessment of treatment-related symptoms in lung cancer between healthcare professionals and patients, and factors contributing to these discrepancies. Materials And Methods: Data...
4.
Rosas J, Aguado-Barrera M, Azria D, Briers E, Elliott R, Farcy-Jacquet M, et al.
Int J Cancer
. 2023 Nov;
154(4):759-761.
PMID: 37908014
No abstract available.
5.
Naderi E, Aguado-Barrera M, Schack L, Dorling L, Rattay T, Fachal L, et al.
JNCI Cancer Spectr
. 2023 Oct;
7(6).
PMID: 37862240
Background: This study was designed to identify common genetic susceptibility and shared genetic variants associated with acute radiation-induced toxicity across 4 cancer types (prostate, head and neck, breast, and lung)....
6.
Jandu H, Veal C, Fachal L, Luccarini C, Aguado-Barrera M, Altabas M, et al.
Radiother Oncol
. 2023 Jul;
187:109806.
PMID: 37437607
Background And Purpose: Up to a quarter of breast cancer patients treated by surgery and radiotherapy experience clinically significant toxicity. If patients at high risk of adverse effects could be...
7.
Rosas J, Aguado-Barrera M, Azria D, Briers E, Elliott R, Farcy-Jacquet M, et al.
Int J Cancer
. 2023 Jul;
153(9):1579-1591.
PMID: 37403702
Fatigue is common in breast-cancer survivors. Our study assessed fatigue longitudinally in breast cancer patients receiving adjuvant radiotherapy (RT) and aimed to identify risk factors associated with long-term fatigue and...
8.
Aguado-Barrera M, Sosa-Fajardo P, Gomez-Caamano A, Taboada-Valladares B, Counago F, Lopez-Guerra J, et al.
Lung Cancer
. 2023 Jan;
176:56-74.
PMID: 36621035
Huge technological and biomedical advances have improved the survival and quality of life of lung cancer patients treated with radiotherapy. However, during treatment planning, a probability that the patient will...
9.
Heumann P, Aguado-Barrera M, Avuzzi B, Azria D, Briers E, Bultijnck R, et al.
Radiother Oncol
. 2022 Nov;
178:109426.
PMID: 36442608
Introduction: Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in...
10.
Joseph N, Cicchetti A, McWilliam A, Webb A, Seibold P, Fiorino C, et al.
Front Oncol
. 2022 Nov;
12:937934.
PMID: 36387203
Introduction: We hypothesized that increasing the pelvic integral dose (ID) and a higher dose per fraction correlate with worsening fatigue and functional outcomes in localized prostate cancer (PCa) patients treated...